Jack Khattar
Founder at SUPERNUS PHARMACEUTICALS, INC.
Net worth: 66 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Siebert | M | 84 |
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | 22 years |
| Rachael Nokes | F | 49 | 10 years | |
| Alan Crane | M | 60 |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Frederick Hudson | M | 78 | 14 years | |
| Padmanabh P. Bhatt | M | 66 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | 21 years |
| Thomas Hughes | M | 64 |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | 6 years |
| John Tucker | M | 61 | 7 years | |
| Lisa Ricciardi | F | 64 | 5 years | |
| Charles Newhall | M | 79 | 19 years | |
| Peggy Wallace | F | 67 | 8 years | |
| Frank Mottola | M | 52 | 19 years | |
| Leonard Schaeffer | M | 78 | 10 years | |
| Katherine Taudvin | F | - | - | |
| Mette Agger | F | 59 | 10 years | |
| Greg Parekh | M | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 14 years |
| Aaron Fletcher | M | 44 | 9 years | |
| Jonathan Rubin | M | 62 | 4 years | |
| Sara Bonstein | F | 43 | 4 years | |
| Minnie Baylor-Henry | F | 76 | 6 years | |
| William Abraham | M | 64 | 3 years | |
| John Doyle | M | 46 | 1 years | |
| David Michael Madden | M | 61 |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Georges Gemayel | M | 64 | 9 years | |
| Klaus Veitinger | M | 62 | 7 years | |
| Ivan Philip Gergel | M | 64 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 6 years |
| Brett Monia | M | 62 | 4 years | |
| Rick Lundberg | M | - |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Ellen Richstone | F | 72 | 3 years | |
| Carrolee Barlow | M | 60 | 6 years | |
| Bethany Sensenig | F | 48 | 1 years | |
| Bryan A. Roecklein | M | - | 9 years | |
| Todd Horich | M | - | 6 years | |
| Taylor Raiford | M | - | 9 years | |
| Brendan Manning | M | - |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Akhil Akula | M | - |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 2 years |
| Mary Hamby | M | - | - | |
| Paul J. Tiseo | M | - | 2 years | |
| John Mohr | M | - | 7 years | |
| Anthony Caggiano | M | 54 | 5 years | |
| Nishant Rastogi | M | - |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 5 years |
| Vinzenz Ploerer | M | - |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Marian Nakada | M | - |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Subhanu Saxena | M | 59 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 7 years |
| Laurie Boyer | F | - |
Rockville Economic Development, Inc.
 Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Rockville Economic Development, Inc. is a public-private partnership that aims to strengthen and broaden the economy of Rockville, MD through entrepreneurship, attraction, expansion, retention, and incentive programs. The non-profit company provides useful research and statistics about demographics, workforce, and business in Rockville to help businesses succeed. Rockville is an ideal place for business success, particularly in key industries such as biohealth and tech. The company also creates partnerships throughout the community to expand a network of services and offer critical resources for small businesses. | 12 years |
| Mike Hassman | M | - | 6 years | |
| Timothy Dec | M | 66 | 3 years | |
| Tami Martin | F | 68 | 16 years | |
| John W. Creecy | M | - |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Michel Lucien Pettigrew | M | 71 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Kevin T. Anderson | M | 61 | 12 years | |
| Rajeev Dadoo | M | 54 |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | - |
| Jeremy Levin | M | 70 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Douglas Giordano | M | 61 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Shankar Hariharan | M | - |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Ian B | M | - |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Bigham | M | 66 | 13 years | |
| Troy Ignelzi | M | 56 | 3 years | |
| Kenneth Moch | M | 69 | 4 years | |
| David Mahoney | M | 69 | 12 years | |
| Susan M. Catalano | M | 60 | 15 years | |
| William A. Nuerge | M | 71 | 12 years | |
| Spyridon Papapetropoulos | M | 52 | 1 years | |
| Christopher B. Prentiss | M | 49 | 6 years | |
| Abhay Gandhi | M | 59 | 2 years | |
| Dorothy A. Coleman | F | 61 | 5 years | |
| Kush Parmar | M | 42 | 4 years | |
| Robert J. Gailus | M | - | 12 years | |
| Jones Woody Bryan | M | 59 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | 15 years |
| Michael Barrett | M | 81 | 11 years | |
| Steven B. Ratoff | M | 81 |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | 9 years |
| Gregory S. Patrick | M | 72 | - | |
| Bill Ericson | M | 65 | 16 years | |
| John A. MacPhee | M | 56 | 8 years | |
| Anna Richo | F | 63 | 1 years | |
| Martha Demski | F | 71 | 7 years | |
| Michael Bart Sheffery | M | 73 | 7 years | |
| Jonathan Silverstein | M | 57 | 1 years | |
| Julie M. Clifford | F | - | - | |
| Andrew Einhorn | M | 64 | 1 years | |
| Robert S. Cohen | M | 81 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | 2 years |
| Abraham Ceesay | M | 46 | 2 years | |
| Adrian Quartel | M | 63 | 2 years | |
| Vijay Shreedhar | M | 53 | 2 years | |
| Sarah Mathieson | F | - | - | |
| Jill M. Jene | M | 51 | 1 years | |
| Paolo Baroldi | M | 73 | 3 years | |
| Eric C. Schlezinger | M | - | - | |
| James O'Brien | M | 57 | 3 years | |
| Dorothy Engelking | F | 63 | 2 years | |
| Beth A. Burnside | M | 63 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | 9 years |
| Victor L. Vaughn | M | 66 | 5 years | |
| Mark H. Breedlove | M | - | - | |
| Stefan Schwabe | M | 72 | 8 years | |
| Russell Wilson | M | 64 | - | |
| James Kelly | M | 58 | 1 years | |
| Robert Z. Arnold | M | - |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | 8 years |
| Chad G. Neely | M | - | - | |
| Mason W. Freeman | M | 73 | 2 years | |
| Sally Sternbach | F | - |
Rockville Economic Development, Inc.
Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Rockville Economic Development, Inc. is a public-private partnership that aims to strengthen and broaden the economy of Rockville, MD through entrepreneurship, attraction, expansion, retention, and incentive programs. The non-profit company provides useful research and statistics about demographics, workforce, and business in Rockville to help businesses succeed. Rockville is an ideal place for business success, particularly in key industries such as biohealth and tech. The company also creates partnerships throughout the community to expand a network of services and offer critical resources for small businesses. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jack Khattar
- Personal Network
